Teslac

Known as: Bristol Myers Squibb Brand of Testolactone, Bristol-Myers Squibb Brand of Testolactone 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1981-2015
01219812015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Using β-sitosterol and stigmasterol as precursor materials, a concise and efficient hemisynthesis of aromatase inhibitors… (More)
Is this relevant?
1994
1994
Premenopausal women have a lower risk of coronary artery disease than men or postmenopausal women; estrogens are thought to… (More)
Is this relevant?
1991
1991
To our knowledge, the action of estradiol which is produced from testosterone by aromatase on human spermatogenesis has not been… (More)
Is this relevant?
1987
1987
Two aromatase inhibitors, 4-hydroxyandrostenedione (4-OHA) and testololactone (Teslac), were tested to determine their effects on… (More)
Is this relevant?
1982
1982
The antiandrogenic properties of delta 1-testolactone (17 alpha-oxa-D-homo-1,4-androstane-3,17-dione; Teslac) were investigated… (More)
Is this relevant?
1981
1981
Ten men with idiopathic oligospermia were treated with delta 1-testolactone (Teslac), a potent inhibitor of conversion of… (More)
Is this relevant?
Review
1981
Review
1981
Increased response rates with nonhormonal combination chemotherapy have led many oncologists to deprecate the use of hormonal… (More)
Is this relevant?